Clinical Trials Logo
  1. Home
  2. Infarction, Myocardial
  3. NCT00196261
  4. Details
NCT00196261 Clinical Trial

Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term Prediction

Infarction, Myocardial Clinical Trial

Official title:
Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term Prediction

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00196261
Other study ID # GE IDE No. R00195
Secondary ID
Status Completed
Phase N/A
First received September 13, 2005
Last updated March 9, 2018
Start date January 1995

Study information
Verified date September 2005
Source Deutsches Herzzentrum Muenchen
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to investigate the performance of established and new risk preditors in predicting long term-mortality (up to ten years) of post-infarction patients.

Recruitment information / eligibility
Status Completed
Enrollment 3500
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

acute myocardial infarction

Exclusion Criteria:

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Germany 1. Medizinische Klinik, Klinikum rechts der Isar Munich
Germany Deutsches Herzzentrum Muenchen Munich

Sponsors (1)
Lead Sponsor Collaborator
Deutsches Herzzentrum Muenchen

Country where clinical trial is conducted

Germany, 

References & Publications (4)

Barthel P, Schneider R, Bauer A, Ulm K, Schmitt C, Schömig A, Schmidt G. Risk stratification after acute myocardial infarction by heart rate turbulence. Circulation. 2003 Sep 9;108(10):1221-6. Epub 2003 Aug 25. — View Citation

Bauer A, Guzik P, Barthel P, Schneider R, Ulm K, Watanabe MA, Schmidt G. Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era. Eur Heart J. 2005 Apr;26(8):755-61. Epub 2005 Jan 26. — View Citation

Mäkikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP, Schmidt G, Huikuri HV. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J. 2005 Apr;26(8):762-9 — View Citation

Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, Camm AJ, Bigger JT Jr, Schömig A. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet. 1999 Apr 24;353(9162):1390-6. — View Citation

See also
  Status Clinical Trial Phase
Completed NCT00426751 - Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI) Phase 3
Completed NCT00196274 - Autonomic Regulation Trial (ART) N/A
Recruiting NCT04000412 - A Novel Myocardial Impedance Mapping System for Ablation of Post-infarction Ventricular Arrhytmias in Humans
Completed NCT03122210 - Comparaison of 2 SpO2 Level Measured by Pulse Oxymetry in Complications of Acute Coronary Syndrome. N/A
Completed NCT04096079 - Post-ROSC Electrocardiogram After Cardiac arrEst
Completed NCT05123885 - Wearable Then Implantable Cardiac Defibrillator After Myocardial Infarction